AR043259A1 - Metodo para el tratamiento de insuficiencia cardiaca severa y medicamento para ello - Google Patents

Metodo para el tratamiento de insuficiencia cardiaca severa y medicamento para ello

Info

Publication number
AR043259A1
AR043259A1 ARP040100557A ARP040100557A AR043259A1 AR 043259 A1 AR043259 A1 AR 043259A1 AR P040100557 A ARP040100557 A AR P040100557A AR P040100557 A ARP040100557 A AR P040100557A AR 043259 A1 AR043259 A1 AR 043259A1
Authority
AR
Argentina
Prior art keywords
treatment
medication
cardiac insufficiency
halogen
salt
Prior art date
Application number
ARP040100557A
Other languages
English (en)
Spanish (es)
Inventor
A Ozaki
Y Maki
Tetsuya Sato
Y Yamamura
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32908667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR043259(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of AR043259A1 publication Critical patent/AR043259A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP040100557A 2003-02-24 2004-02-23 Metodo para el tratamiento de insuficiencia cardiaca severa y medicamento para ello AR043259A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44887803P 2003-02-24 2003-02-24

Publications (1)

Publication Number Publication Date
AR043259A1 true AR043259A1 (es) 2005-07-20

Family

ID=32908667

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040100557A AR043259A1 (es) 2003-02-24 2004-02-23 Metodo para el tratamiento de insuficiencia cardiaca severa y medicamento para ello

Country Status (23)

Country Link
US (2) US7423032B2 (https=)
EP (2) EP2000142A1 (https=)
JP (2) JP4771937B2 (https=)
KR (1) KR100706727B1 (https=)
CN (1) CN100577171C (https=)
AR (1) AR043259A1 (https=)
AT (1) ATE411803T1 (https=)
AU (2) AU2004212842B9 (https=)
BR (1) BRPI0405657A (https=)
CA (1) CA2493475A1 (https=)
CY (1) CY1108583T1 (https=)
DE (1) DE602004017283D1 (https=)
DK (1) DK1596868T3 (https=)
ES (1) ES2315640T3 (https=)
MX (1) MXPA05001623A (https=)
MY (1) MY143740A (https=)
NO (1) NO335369B1 (https=)
PL (2) PL404315A1 (https=)
PT (1) PT1596868E (https=)
RU (2) RU2346689C2 (https=)
SI (1) SI1596868T1 (https=)
TW (1) TWI322689B (https=)
WO (1) WO2004073716A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7468390B2 (en) * 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
TWI322689B (en) * 2003-02-24 2010-04-01 Otsuka Pharma Co Ltd Method for treating severe heart failure and medicament therefor
DE102005003632A1 (de) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter für die transvaskuläre Implantation von Herzklappenprothesen
US20070213813A1 (en) 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
DK1968990T3 (da) 2005-12-27 2015-04-27 Otsuka Pharma Co Ltd Vandopløselig benzoazepinforbindelse og farmaceutisk sammensætning deraf
JP5076327B2 (ja) * 2006-02-01 2012-11-21 味の素株式会社 分岐鎖アミノ酸の心不全適応
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
PT2146721E (pt) * 2007-05-15 2013-07-18 Otsuka Pharma Co Ltd Métodos de utilização de antagonistas da vasopressina com agentes quimioterapeuticos de antraciclina para reduzir a cardiotoxicidade e/ou melhorar a sobrevivência
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
WO2011104269A1 (en) 2008-02-26 2011-09-01 Jenavalve Technology Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US10856978B2 (en) 2010-05-20 2020-12-08 Jenavalve Technology, Inc. Catheter system
CN103002833B (zh) 2010-05-25 2016-05-11 耶拿阀门科技公司 人工心脏瓣及包括人工心脏瓣和支架的经导管输送的内假体
JP5477413B2 (ja) * 2012-04-24 2014-04-23 味の素株式会社 分岐鎖アミノ酸の心不全適応
WO2015028209A1 (en) 2013-08-30 2015-03-05 Jenavalve Technology Gmbh Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
WO2016150806A1 (en) 2015-03-20 2016-09-29 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath
CN107530168B (zh) 2015-05-01 2020-06-09 耶拿阀门科技股份有限公司 在心脏瓣膜替换中具有降低的起搏器比例的装置和方法
CN109475419B (zh) 2016-05-13 2021-11-09 耶拿阀门科技股份有限公司 用于通过引导鞘和装载系统来递送心脏瓣膜假体的心脏瓣膜假体递送系统和方法
CN110392557A (zh) 2017-01-27 2019-10-29 耶拿阀门科技股份有限公司 心脏瓣膜模拟
CN110174474B (zh) * 2019-05-24 2022-02-18 石家庄四药有限公司 复方电解质注射液(ⅱ)中l-苹果酸异构体的检测方法
CN112121051B (zh) * 2020-09-30 2021-06-18 郑州大学 莫扎伐坦在制备抗消化道肿瘤药物中的应用
CN120152682A (zh) 2022-11-09 2025-06-13 耶拿阀门科技公司 用于顺序地部署可扩张植入物的导管系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01102124A (ja) 1987-10-14 1989-04-19 Kubota Ltd コンクリート構造体支持構造
US5753677A (en) * 1989-10-20 1998-05-19 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
US5258510A (en) 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
DK0450097T3 (da) 1989-10-20 1996-05-20 Otsuka Pharma Co Ltd Benzoheterocykliske forbindelser
AU657424B2 (en) 1992-07-02 1995-03-09 Otsuka Pharmaceutical Co., Ltd. Oxytocin antagonist
JPH0680641A (ja) 1992-09-01 1994-03-22 Otsuka Pharmaceut Co Ltd 光学活性な５−ヒドロキシベンゾアゼピン誘導体の製造法
TW354762B (en) 1993-02-23 1999-03-21 Otsuka Pharma Co Ltd Agent for prophylaxis or treatment of cataract
JP2694319B2 (ja) 1993-12-24 1997-12-24 大塚製薬株式会社 抗潰瘍剤
JP3002766B2 (ja) 1994-12-09 2000-01-24 大塚製薬株式会社 脳浮腫治療剤
JPH10120592A (ja) 1996-10-22 1998-05-12 Otsuka Pharmaceut Co Ltd メニエール病乃至メニエール症候群治療剤
JP4210355B2 (ja) 1997-07-03 2009-01-14 大塚製薬株式会社 固形製剤組成物
EP1253945B1 (en) 2000-01-26 2006-10-04 Astellas Pharma Inc. Ace inhibitor-vasopressin antagonist combinations
US20030103983A1 (en) * 2002-05-09 2003-06-05 Pressler Milton Lethan Ace inhibitor-vasopressin antagonist combinations
US20030008860A1 (en) 2002-05-09 2003-01-09 Bakker-Arkema Rebecca Guggemos Treatment of congestive heart failure
ES2288899T3 (es) * 2000-10-04 2008-02-01 Astellas Pharma Inc. Uso de un antagonista de vasopresina tal como conivaptan en la fabricacion de un medicamento para el tratamiento de la hipertension pulmonar.
TWI322689B (en) * 2003-02-24 2010-04-01 Otsuka Pharma Co Ltd Method for treating severe heart failure and medicament therefor

Also Published As

Publication number Publication date
EP1596868A4 (en) 2006-03-29
JP2011148806A (ja) 2011-08-04
AU2004212842B9 (en) 2009-03-05
EP1596868B1 (en) 2008-10-22
NO335369B1 (no) 2014-12-01
ATE411803T1 (de) 2008-11-15
HK1084037A1 (zh) 2006-07-21
KR20050105972A (ko) 2005-11-08
US20080214523A1 (en) 2008-09-04
AU2004212842A1 (en) 2004-09-02
NO20050569L (no) 2005-11-22
CY1108583T1 (el) 2014-04-09
PL404315A1 (pl) 2013-08-05
ES2315640T3 (es) 2009-04-01
EP2000142A1 (en) 2008-12-10
US20050187210A1 (en) 2005-08-25
PL218069B1 (pl) 2014-10-31
TW200418489A (en) 2004-10-01
RU2346689C2 (ru) 2009-02-20
RU2008133654A (ru) 2010-02-20
RU2005102110A (ru) 2005-09-20
KR100706727B1 (ko) 2007-04-12
EP1596868A1 (en) 2005-11-23
AU2004212842B2 (en) 2009-01-08
BRPI0405657A (pt) 2005-07-19
CA2493475A1 (en) 2004-09-02
US7749993B2 (en) 2010-07-06
SI1596868T1 (sl) 2008-12-31
JP4771937B2 (ja) 2011-09-14
MY143740A (en) 2011-07-15
JP2006518731A (ja) 2006-08-17
DE602004017283D1 (de) 2008-12-04
NO20050569D0 (no) 2005-02-02
PT1596868E (pt) 2009-01-14
CN100577171C (zh) 2010-01-06
AU2009201109A1 (en) 2009-04-09
DK1596868T3 (da) 2008-12-08
CN1700919A (zh) 2005-11-23
TWI322689B (en) 2010-04-01
PL373432A1 (en) 2005-08-22
MXPA05001623A (es) 2005-04-25
WO2004073716A1 (en) 2004-09-02
US7423032B2 (en) 2008-09-09

Similar Documents

Publication Publication Date Title
AR043259A1 (es) Metodo para el tratamiento de insuficiencia cardiaca severa y medicamento para ello
ES2566973T3 (es) Uso de SNS-595 para tratar leucemia
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
NO20052914L (no) Terapeutiske forbindelser
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
WO2005063745A3 (en) Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof
AR036044A1 (es) Compuestos piranoindazoles, composiciones farmaceuticas y su uso para la manufactura de un medicamento para el tratamiento del glaucoma
EA200101005A1 (ru) Высокоэффективные композиции, содержащие дигидроэрготамин
MXPA05007857A (es) Moduladores derivados de indol de receptores nucleares de hormonas esteroideas.
UA107578C2 (uk) Комбінована терапія при лікуванні діабету
NO20076425L (no) Fremgangsmater for behandling av drug-resistent cancer
CY1113890T1 (el) Φαρμακευτικοι συνδυασμοι που περιεχουν βενζοξαζινες για τη θεραπεια νοσων των αναπνευστικων οδων
MXPA04005156A (es) Antagonistas del receptor de adenosina a2a.
MXPA05012810A (es) Formas de dosis oral de memantina.
TW200738698A (en) Organic compounds
RU2011117927A (ru) Карбаматное соединение или его соль
TW200700061A (en) Organic compounds
BR0210392A (pt) Composto, métodos de tratar um paciente que tenha ou de prevenir um paciente de contrair uma doença ou condição e de preparar um composto, e, uso de um composto
UY29085A1 (es) Derivados de pirimidina 4-sulfonamido sustituidos, compuestos intermedios para su preparación, procedimientos de preparación, composiciones medicinales conteniéndolos y aplicaci0nes
DOP2005000039A (es) Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)- piperidin-1-il]-(4-bomo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
AR048197A1 (es) Metodos para tratar la esquizofrenia y/o anomalias de glucorregulacion
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли
WO2006125194A3 (en) Piperazine derivatives and their uses as therapeutic agents
EA200900269A1 (ru) Лекарственные комбинации для лечения заболеваний дыхательных путей
AR044869A1 (es) Compuesto de dicetopiperazina, composicion farmaceutica que lo comprende, su uso para fabricar un medicamento y procedimiento para su preparacion

Legal Events

Date Code Title Description
FB Suspension of granting procedure